HEADER MEMBRANE PROTEIN 21-APR-24 8Z7S TITLE SLC19A3-THIAMINE OUTWARD STRUCTURE COMPND MOL_ID: 1; COMPND 2 MOLECULE: THIAMINE TRANSPORTER 2; COMPND 3 CHAIN: A; COMPND 4 SYNONYM: THTR-2,THTR2,SOLUTE CARRIER FAMILY 19 MEMBER 3; COMPND 5 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 GENE: SLC19A3; SOURCE 6 EXPRESSION_SYSTEM: SPODOPTERA FRUGIPERDA; SOURCE 7 EXPRESSION_SYSTEM_TAXID: 7108 KEYWDS THIAMINE TRANSPORTER, MFS, MEMBRANE PROTEIN EXPDTA ELECTRON MICROSCOPY AUTHOR P.P.LI,Z.N.ZHU,Y.WANG,P.GAO,Q.H.QU REVDAT 1 08-JAN-25 8Z7S 0 JRNL AUTH P.LI,Z.ZHU,Y.WANG,X.ZHANG,C.YANG,Y.ZHU,Z.ZHOU,Y.CHAO,Y.LONG, JRNL AUTH 2 Y.GAO,S.LIU,L.ZHANG,P.GAO,Q.QU JRNL TITL SUBSTRATE TRANSPORT AND DRUG INTERACTION OF HUMAN THIAMINE JRNL TITL 2 TRANSPORTERS SLC19A2/A3. JRNL REF NAT COMMUN V. 15 10924 2024 JRNL REFN ESSN 2041-1723 JRNL PMID 39738067 JRNL DOI 10.1038/S41467-024-55359-8 REMARK 2 REMARK 2 RESOLUTION. 3.05 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 SOFTWARE PACKAGES : NULL REMARK 3 RECONSTRUCTION SCHEMA : NULL REMARK 3 REMARK 3 EM MAP-MODEL FITTING AND REFINEMENT REMARK 3 PDB ENTRY : NULL REMARK 3 REFINEMENT SPACE : NULL REMARK 3 REFINEMENT PROTOCOL : NULL REMARK 3 REFINEMENT TARGET : NULL REMARK 3 OVERALL ANISOTROPIC B VALUE : NULL REMARK 3 REMARK 3 FITTING PROCEDURE : NULL REMARK 3 REMARK 3 EM IMAGE RECONSTRUCTION STATISTICS REMARK 3 NOMINAL PIXEL SIZE (ANGSTROMS) : NULL REMARK 3 ACTUAL PIXEL SIZE (ANGSTROMS) : NULL REMARK 3 EFFECTIVE RESOLUTION (ANGSTROMS) : 3.050 REMARK 3 NUMBER OF PARTICLES : 254415 REMARK 3 CTF CORRECTION METHOD : PHASE FLIPPING AND AMPLITUDE REMARK 3 CORRECTION REMARK 3 REMARK 3 EM RECONSTRUCTION MAGNIFICATION CALIBRATION: NULL REMARK 3 REMARK 3 OTHER DETAILS: NULL REMARK 4 REMARK 4 8Z7S COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY PDBC ON 27-APR-24. REMARK 100 THE DEPOSITION ID IS D_1300047184. REMARK 245 REMARK 245 EXPERIMENTAL DETAILS REMARK 245 RECONSTRUCTION METHOD : SINGLE PARTICLE REMARK 245 SPECIMEN TYPE : NULL REMARK 245 REMARK 245 ELECTRON MICROSCOPE SAMPLE REMARK 245 SAMPLE TYPE : PARTICLE REMARK 245 PARTICLE TYPE : POINT REMARK 245 NAME OF SAMPLE : SLC19A3 REMARK 245 SAMPLE CONCENTRATION (MG ML-1) : NULL REMARK 245 SAMPLE SUPPORT DETAILS : NULL REMARK 245 SAMPLE VITRIFICATION DETAILS : NULL REMARK 245 SAMPLE BUFFER : NULL REMARK 245 PH : 7.50 REMARK 245 SAMPLE DETAILS : NULL REMARK 245 REMARK 245 DATA ACQUISITION REMARK 245 DATE OF EXPERIMENT : NULL REMARK 245 NUMBER OF MICROGRAPHS-IMAGES : NULL REMARK 245 TEMPERATURE (KELVIN) : NULL REMARK 245 MICROSCOPE MODEL : FEI TALOS ARCTICA REMARK 245 DETECTOR TYPE : GATAN K2 QUANTUM (4K X 4K) REMARK 245 MINIMUM DEFOCUS (NM) : 1200.00 REMARK 245 MAXIMUM DEFOCUS (NM) : 1500.00 REMARK 245 MINIMUM TILT ANGLE (DEGREES) : NULL REMARK 245 MAXIMUM TILT ANGLE (DEGREES) : NULL REMARK 245 NOMINAL CS : NULL REMARK 245 IMAGING MODE : BRIGHT FIELD REMARK 245 ELECTRON DOSE (ELECTRONS NM**-2) : 6000.00 REMARK 245 ILLUMINATION MODE : FLOOD BEAM REMARK 245 NOMINAL MAGNIFICATION : NULL REMARK 245 CALIBRATED MAGNIFICATION : NULL REMARK 245 SOURCE : FIELD EMISSION GUN REMARK 245 ACCELERATION VOLTAGE (KV) : 200 REMARK 245 IMAGING DETAILS : NULL REMARK 247 REMARK 247 ELECTRON MICROSCOPY REMARK 247 THE COORDINATES IN THIS ENTRY WERE GENERATED FROM ELECTRON REMARK 247 MICROSCOPY DATA. PROTEIN DATA BANK CONVENTIONS REQUIRE REMARK 247 THAT CRYST1 AND SCALE RECORDS BE INCLUDED, BUT THE VALUES REMARK 247 ON THESE RECORDS ARE MEANINGLESS EXCEPT FOR THE CALCULATION REMARK 247 OF THE STRUCTURE FACTORS. REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: MONOMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 MET A 1 REMARK 465 ASP A 2 REMARK 465 CYS A 3 REMARK 465 TYR A 4 REMARK 465 ARG A 5 REMARK 465 THR A 6 REMARK 465 SER A 7 REMARK 465 LEU A 8 REMARK 465 SER A 9 REMARK 465 SER A 10 REMARK 465 MET A 197 REMARK 465 PHE A 198 REMARK 465 PHE A 199 REMARK 465 HIS A 200 REMARK 465 ALA A 201 REMARK 465 LYS A 202 REMARK 465 PRO A 203 REMARK 465 SER A 204 REMARK 465 ARG A 205 REMARK 465 GLU A 206 REMARK 465 ILE A 207 REMARK 465 LYS A 208 REMARK 465 LYS A 209 REMARK 465 SER A 210 REMARK 465 SER A 211 REMARK 465 SER A 212 REMARK 465 VAL A 213 REMARK 465 ASN A 214 REMARK 465 PRO A 215 REMARK 465 VAL A 216 REMARK 465 LEU A 217 REMARK 465 GLU A 218 REMARK 465 GLU A 219 REMARK 465 THR A 220 REMARK 465 HIS A 221 REMARK 465 GLU A 222 REMARK 465 GLY A 223 REMARK 465 GLU A 224 REMARK 465 ALA A 225 REMARK 465 PRO A 226 REMARK 465 GLY A 227 REMARK 465 CYS A 228 REMARK 465 GLU A 229 REMARK 465 GLU A 230 REMARK 465 GLN A 231 REMARK 465 LYS A 232 REMARK 465 PRO A 233 REMARK 465 THR A 234 REMARK 465 SER A 235 REMARK 465 GLU A 236 REMARK 465 ILE A 237 REMARK 465 LEU A 238 REMARK 465 SER A 239 REMARK 465 THR A 240 REMARK 465 SER A 241 REMARK 465 GLY A 242 REMARK 465 LYS A 243 REMARK 465 LEU A 244 REMARK 465 ASN A 245 REMARK 465 LYS A 246 REMARK 465 GLY A 247 REMARK 465 GLN A 248 REMARK 465 LEU A 249 REMARK 465 ASN A 250 REMARK 465 SER A 251 REMARK 465 LEU A 252 REMARK 465 LYS A 253 REMARK 465 PRO A 254 REMARK 465 SER A 255 REMARK 465 ASN A 256 REMARK 465 VAL A 257 REMARK 465 THR A 258 REMARK 465 VAL A 259 REMARK 465 ASP A 260 REMARK 465 TYR A 462 REMARK 465 SER A 463 REMARK 465 THR A 464 REMARK 465 LYS A 465 REMARK 465 SER A 466 REMARK 465 GLN A 467 REMARK 465 LYS A 468 REMARK 465 ASP A 469 REMARK 465 VAL A 470 REMARK 465 GLN A 471 REMARK 465 SER A 472 REMARK 465 PRO A 473 REMARK 465 ALA A 474 REMARK 465 PRO A 475 REMARK 465 SER A 476 REMARK 465 GLU A 477 REMARK 465 ASN A 478 REMARK 465 PRO A 479 REMARK 465 ASP A 480 REMARK 465 VAL A 481 REMARK 465 SER A 482 REMARK 465 HIS A 483 REMARK 465 PRO A 484 REMARK 465 GLU A 485 REMARK 465 GLU A 486 REMARK 465 GLU A 487 REMARK 465 SER A 488 REMARK 465 ASN A 489 REMARK 465 ILE A 490 REMARK 465 ILE A 491 REMARK 465 MET A 492 REMARK 465 SER A 493 REMARK 465 THR A 494 REMARK 465 LYS A 495 REMARK 465 LEU A 496 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 SER A 40 79.81 -100.68 REMARK 500 TYR A 79 -12.62 70.66 REMARK 500 ARG A 277 9.94 57.83 REMARK 500 ALA A 367 51.78 -91.01 REMARK 500 ASN A 399 12.81 56.44 REMARK 500 REMARK 500 REMARK: NULL REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: EMD-39826 RELATED DB: EMDB REMARK 900 SLC19A3-THIAMINE OUTWARD STRUCTURE DBREF 8Z7S A 1 496 UNP Q9BZV2 S19A3_HUMAN 1 496 SEQRES 1 A 496 MET ASP CYS TYR ARG THR SER LEU SER SER SER TRP ILE SEQRES 2 A 496 TYR PRO THR VAL ILE LEU CYS LEU PHE GLY PHE PHE SER SEQRES 3 A 496 MET MET ARG PRO SER GLU PRO PHE LEU ILE PRO TYR LEU SEQRES 4 A 496 SER GLY PRO ASP LYS ASN LEU THR SER ALA GLU ILE THR SEQRES 5 A 496 ASN GLU ILE PHE PRO VAL TRP THR TYR SER TYR LEU VAL SEQRES 6 A 496 LEU LEU LEU PRO VAL PHE VAL LEU THR ASP TYR VAL ARG SEQRES 7 A 496 TYR LYS PRO VAL ILE ILE LEU GLN GLY ILE SER PHE ILE SEQRES 8 A 496 ILE THR TRP LEU LEU LEU LEU PHE GLY GLN GLY VAL LYS SEQRES 9 A 496 THR MET GLN VAL VAL GLU PHE PHE TYR GLY MET VAL THR SEQRES 10 A 496 ALA ALA GLU VAL ALA TYR TYR ALA TYR ILE TYR SER VAL SEQRES 11 A 496 VAL SER PRO GLU HIS TYR GLN ARG VAL SER GLY TYR CYS SEQRES 12 A 496 ARG SER VAL THR LEU ALA ALA TYR THR ALA GLY SER VAL SEQRES 13 A 496 LEU ALA GLN LEU LEU VAL SER LEU ALA ASN MET SER TYR SEQRES 14 A 496 PHE TYR LEU ASN VAL ILE SER LEU ALA SER VAL SER VAL SEQRES 15 A 496 ALA PHE LEU PHE SER LEU PHE LEU PRO MET PRO LYS LYS SEQRES 16 A 496 SER MET PHE PHE HIS ALA LYS PRO SER ARG GLU ILE LYS SEQRES 17 A 496 LYS SER SER SER VAL ASN PRO VAL LEU GLU GLU THR HIS SEQRES 18 A 496 GLU GLY GLU ALA PRO GLY CYS GLU GLU GLN LYS PRO THR SEQRES 19 A 496 SER GLU ILE LEU SER THR SER GLY LYS LEU ASN LYS GLY SEQRES 20 A 496 GLN LEU ASN SER LEU LYS PRO SER ASN VAL THR VAL ASP SEQRES 21 A 496 VAL PHE VAL GLN TRP PHE GLN ASP LEU LYS GLU CYS TYR SEQRES 22 A 496 SER SER LYS ARG LEU PHE TYR TRP SER LEU TRP TRP ALA SEQRES 23 A 496 PHE ALA THR ALA GLY PHE ASN GLN VAL LEU ASN TYR VAL SEQRES 24 A 496 GLN ILE LEU TRP ASP TYR LYS ALA PRO SER GLN ASP SER SEQRES 25 A 496 SER ILE TYR ASN GLY ALA VAL GLU ALA ILE ALA THR PHE SEQRES 26 A 496 GLY GLY ALA VAL ALA ALA PHE ALA VAL GLY TYR VAL LYS SEQRES 27 A 496 VAL ASN TRP ASP LEU LEU GLY GLU LEU ALA LEU VAL VAL SEQRES 28 A 496 PHE SER VAL VAL ASN ALA GLY SER LEU PHE LEU MET HIS SEQRES 29 A 496 TYR THR ALA ASN ILE TRP ALA CYS TYR ALA GLY TYR LEU SEQRES 30 A 496 ILE PHE LYS SER SER TYR MET LEU LEU ILE THR ILE ALA SEQRES 31 A 496 VAL PHE GLN ILE ALA VAL ASN LEU ASN VAL GLU ARG TYR SEQRES 32 A 496 ALA LEU VAL PHE GLY ILE ASN THR PHE ILE ALA LEU VAL SEQRES 33 A 496 ILE GLN THR ILE MET THR VAL ILE VAL VAL ASP GLN ARG SEQRES 34 A 496 GLY LEU ASN LEU PRO VAL SER ILE GLN PHE LEU VAL TYR SEQRES 35 A 496 GLY SER TYR PHE ALA VAL ILE ALA GLY ILE PHE LEU MET SEQRES 36 A 496 ARG SER MET TYR ILE THR TYR SER THR LYS SER GLN LYS SEQRES 37 A 496 ASP VAL GLN SER PRO ALA PRO SER GLU ASN PRO ASP VAL SEQRES 38 A 496 SER HIS PRO GLU GLU GLU SER ASN ILE ILE MET SER THR SEQRES 39 A 496 LYS LEU HET VIB A 501 18 HETNAM VIB 3-(4-AMINO-2-METHYL-PYRIMIDIN-5-YLMETHYL)-5-(2-HYDROXY- HETNAM 2 VIB ETHYL)-4-METHYL-THIAZOL-3-IUM HETSYN VIB THIAMIN; VITAMIN B1 FORMUL 2 VIB C12 H17 N4 O S 1+ HELIX 1 AA1 TRP A 12 MET A 28 1 17 HELIX 2 AA2 PHE A 34 SER A 40 1 7 HELIX 3 AA3 THR A 47 ILE A 55 1 9 HELIX 4 AA4 ILE A 55 THR A 74 1 20 HELIX 5 AA5 TYR A 79 PHE A 99 1 21 HELIX 6 AA6 GLN A 101 SER A 129 1 29 HELIX 7 AA7 SER A 132 GLU A 134 5 3 HELIX 8 AA8 HIS A 135 ALA A 165 1 31 HELIX 9 AA9 SER A 168 PHE A 189 1 22 HELIX 10 AB1 PHE A 262 TYR A 273 1 12 HELIX 11 AB2 ARG A 277 ALA A 307 1 31 HELIX 12 AB3 ASP A 311 VAL A 337 1 27 HELIX 13 AB4 LEU A 344 THR A 366 1 23 HELIX 14 AB5 ASN A 368 LEU A 398 1 31 HELIX 15 AB6 ARG A 402 VAL A 426 1 25 HELIX 16 AB7 PRO A 434 THR A 461 1 28 CRYST1 1.000 1.000 1.000 90.00 90.00 90.00 P 1 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 1.000000 0.000000 0.000000 0.00000 SCALE2 0.000000 1.000000 0.000000 0.00000 SCALE3 0.000000 0.000000 1.000000 0.00000